Total Payments
$3,061
2024 Payments
$1,038
Companies
19
Transactions
51
Medicare Patients
1,636
Medicare Billing
$99,729
Payment Breakdown by Category
Food & Beverage$3,061 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,061 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $643.55 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $247.88 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $226.80 | 2 | $0 (2024) |
| Amgen Inc. | $161.99 | 6 | $0 (2023) |
| AngioDynamics, Inc. | $158.36 | 2 | $0 (2023) |
| Lilly USA, LLC | $156.73 | 6 | $0 (2023) |
| SCPHARMACEUTICALS INC. | $143.19 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $132.59 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $124.99 | 1 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $124.74 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,038 | 9 | SANOFI-AVENTIS U.S. LLC ($132.59) |
| 2023 | $854.49 | 17 | AngioDynamics, Inc. ($158.36) |
| 2022 | $607.25 | 15 | ABBVIE INC. ($250.50) |
| 2021 | $562.19 | 10 | AbbVie Inc. ($236.04) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $132.59 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Cardio-renal | ||||||
| 08/20/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $97.48 | General |
| 07/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $120.54 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $108.64 | General |
| Category: Biological | ||||||
| 06/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $108.61 | General |
| Category: EPILEPSY | ||||||
| 11/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $134.86 | General |
| Category: Cardiology | ||||||
| 09/07/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Cardiology | ||||||
| 08/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Inflammation | ||||||
| 07/28/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2023 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: PAD | ||||||
| 07/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Biological | ||||||
| 06/01/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Diabetes | ||||||
| 05/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiology | ||||||
| 05/16/2023 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $129.17 | General |
| Category: PAD | ||||||
| 04/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $107.10 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $88.12 | General |
| 02/21/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: CONTRACEPTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 415 | 562 | $115,258 | $29,884 |
| 2022 | 11 | 468 | 660 | $120,823 | $30,396 |
| 2021 | 12 | 432 | 592 | $99,979 | $25,655 |
| 2020 | 12 | 321 | 378 | $58,779 | $13,794 |
Total Patients
1,636
Total Services
2,192
Medicare Billing
$99,729
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 174 | $53,300 | $11,216 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $25,151 | $7,847 | 31.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $13,975 | $3,649 | 26.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $6,625 | $1,795 | 27.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 12 | 12 | $4,764 | $1,542 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 110 | 181 | $2,910 | $1,520 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $4,792 | $1,046 | 21.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $2,430 | $772.20 | 31.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $948.00 | $457.44 | 48.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 18 | $363.00 | $39.60 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 218 | $66,490 | $13,452 | 20.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $22,043 | $7,047 | 32.0% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 14 | 15 | $6,420 | $2,118 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 44 | $9,108 | $1,996 | 21.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 25 | $5,690 | $1,700 | 29.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $4,440 | $1,598 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 28 | $2,280 | $757.62 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 112 | 193 | $1,737 | $572.46 | 33.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 21 | 21 | $1,410 | $571.53 | 40.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 15 | 15 | $765.00 | $534.60 | 69.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 22 | $440.00 | $48.80 | 11.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 182 | $55,510 | $12,360 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 43 | 43 | $14,147 | $4,558 | 32.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 28 | 28 | $6,020 | $1,827 | 30.4% |
| 87636 | Sarscov2 & inf a&b amp prb | Office | 2021 | 11 | 11 | $4,708 | $1,569 | 33.3% |
About Layla Al-Shami, ARNP
Layla Al-Shami, ARNP is a Adult Health healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255483558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Layla Al-Shami, ARNP has received a total of $3,061 in payments from pharmaceutical and medical device companies, with $1,038 received in 2024. These payments were reported across 51 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,061).
As a Medicare-enrolled provider, Al-Shami has provided services to 1,636 Medicare beneficiaries, totaling 2,192 services with total Medicare billing of $99,729. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Other Specialties Adult Health
- Location Louisville, KY
- Active Since 01/17/2007
- Last Updated 05/18/2022
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255483558
Products in Payments
- UBRELVY (Drug) $289.88
- VRAYLAR (Drug) $257.82
- Kerendia (Drug) $226.80
- AURYON LASER SYSTEM 100-120 VAC (Device) $158.36
- FUROSCIX (Drug) $143.19
- MOUNJARO (Drug) $142.82
- TZIELD (Biological) $132.59
- TRELEGY ELLIPTA (Drug) $127.34
- YUPELRI (Drug) $124.99
- NEXTSTELLIS (Drug) $124.74
- Veozah (Drug) $124.15
- Repatha (Biological) $122.80
- AREXVY (Drug) $120.54
- CRYSVITA (Drug) $119.70
- VALTOCO (Drug) $108.61
- Twirla (Drug) $105.82
- Korlym (Drug) $100.00
- Epclusa (Drug) $92.99
- Otezla (Drug) $35.56
- TRULICITY (Drug) $13.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Louisville
Miss. Kimberly Vessels, Np-C, NP-C
Adult Health — Payments: $56,907
Adult Health $56,907
Ms. Heidi Gallo, Arnp, ARNP
Adult Health — Payments: $14,488
Adult Health $14,488
Karen Eastridge, Np-C, Cde, NP-C, CDE
Adult Health — Payments: $9,689
Adult Health $9,689
Mistie Teer, Aprn, APRN
Adult Health — Payments: $7,748
Adult Health $7,748
Amy Baird, Arnp, ARNP
Adult Health — Payments: $5,564
Adult Health $5,564
Amanda Jones, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Adult Health — Payments: $3,428
Adult Health $3,428